Medical History & Labs
Current HF Therapies
|Endpoint:||The MAGGIC risk score only estimates mortality at 1 and 3 years|
Risk of dying within 1 year:
|No Event||Treatment Benefit||Event|
Possible Side Effects
Displayed percentages represent the absolute risk increase compared to placebo (except for sacubitril-valsartan, which was compared to ACE inhibitor). Only differences found to be statistically significant in randomized controlled trials are shown.
Other Treatment Information
HFMedChoice is a decision support tool intended for use by healthcare professionals. It is not meant to be a substitute for professional advice.
Version 2020.1 - © 2020 Ricky Turgeon